Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials.
第一作者:
Paul L,Hess
第一单位:
Duke Clinical Research Institute, Durham, North Carolina 27715, USA. p.hess@duke.edu
作者:
主题词
老年人(Aged);猝死, 心脏(Death, Sudden, Cardiac);除颤器, 植入型(Defibrillators, Implantable);女(雌)性(Female);住院(Hospitalization);人类(Humans);男(雄)性(Male);中年人(Middle Aged);心肌梗死(Myocardial Infarction);一级预防(Primary Prevention);比例危险度模型(Proportional Hazards Models);随机对照试验(主题)(Randomized Controlled Trials as Topic);时间因素(Time Factors)
DOI
10.1016/j.hrthm.2013.02.011
PMID
23416381
发布时间
2024-06-10
- 浏览19
Heart rhythm
828-35页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



